SMART Health Cards: Vaccination & Testing Implementation Guide
1.0.0 - STU1
SMART Health Cards: Vaccination & Testing Implementation Guide
1.0.0 - STU1
SMART Health Cards: Vaccination & Testing Implementation Guide, published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-shc-vaccination-ig/ and changes regularly. See the Directory of published versions
| Page standards status: Trial-use | Maturity Level: 4 |
{
"resourceType" : "ValueSet",
"id" : "immunization-all-cvx",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet immunization-all-cvx</b></p><a name=\"immunization-all-cvx\"> </a><a name=\"hcimmunization-all-cvx\"> </a><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.5.0/CodeSystem-CVX.html\"><code>http://hl7.org/fhir/sid/cvx</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>54</td><td>adenovirus, type 4</td></tr><tr><td>55</td><td>adenovirus, type 7</td></tr><tr><td>82</td><td>adenovirus, unspecified formulation</td></tr><tr><td>24</td><td>Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis</td></tr><tr><td>19</td><td>BCG</td></tr><tr><td>27</td><td>botulinum antitoxin</td></tr><tr><td>26</td><td>cholera, unspecified formulation</td></tr><tr><td>29</td><td>CMVIG</td></tr><tr><td>56</td><td>dengue fever tetravalent</td></tr><tr><td>12</td><td>diphtheria antitoxin</td></tr><tr><td>28</td><td>DT (pediatric)</td></tr><tr><td>20</td><td>DTaP</td></tr><tr><td>106</td><td>DTaP, 5 pertussis antigens</td></tr><tr><td>107</td><td>DTaP, unspecified formulation</td></tr><tr><td>110</td><td>DTaP-Hep B-IPV</td></tr><tr><td>50</td><td>DTaP-Hib</td></tr><tr><td>120</td><td>DTaP-Hib-IPV</td></tr><tr><td>130</td><td>DTaP-IPV</td></tr><tr><td>22</td><td>DTP-Hib</td></tr><tr><td>102</td><td>DTP-Hib-Hep B</td></tr><tr><td>57</td><td>hantavirus</td></tr><tr><td>52</td><td>Hep A, adult</td></tr><tr><td>83</td><td>Hep A, ped/adol, 2 dose</td></tr><tr><td>84</td><td>Hep A, ped/adol, 3 dose</td></tr><tr><td>31</td><td>Hep A, pediatric, unspecified formulation</td></tr><tr><td>85</td><td>Hep A, unspecified formulation</td></tr><tr><td>104</td><td>Hep A-Hep B</td></tr><tr><td>30</td><td>HBIG</td></tr><tr><td>42</td><td>Hep B, adolescent/high risk infant</td></tr><tr><td>43</td><td>Hep B, adult</td></tr><tr><td>44</td><td>Hep B, high-dosage, dialysis or IC</td></tr><tr><td>45</td><td>Hep B, unspecified formulation</td></tr><tr><td>58</td><td>Hep C</td></tr><tr><td>59</td><td>Hep E</td></tr><tr><td>60</td><td>herpes simplex 2</td></tr><tr><td>46</td><td>Hib (PRP-D)</td></tr><tr><td>47</td><td>Hib (HbOC)</td></tr><tr><td>48</td><td>Hib (PRP-T)</td></tr><tr><td>49</td><td>Hib (PRP-OMP)</td></tr><tr><td>17</td><td>Hib, unspecified formulation</td></tr><tr><td>51</td><td>Hib-Hep B</td></tr><tr><td>61</td><td>HIV</td></tr><tr><td>118</td><td>HPV, bivalent</td></tr><tr><td>62</td><td>HPV, quadrivalent</td></tr><tr><td>86</td><td>IG</td></tr><tr><td>87</td><td>IGIV</td></tr><tr><td>14</td><td>IG, unspecified formulation</td></tr><tr><td>111</td><td>Influenza, live, trivalent, intranasal, PF</td></tr><tr><td>15</td><td>influenza, split (incl. purified surface antigen)</td></tr><tr><td>16</td><td>influenza, whole</td></tr><tr><td>88</td><td>influenza, unspecified formulation</td></tr><tr><td>123</td><td>influenza, H5N1-1203</td></tr><tr><td>10</td><td>IPV</td></tr><tr><td>89</td><td>polio, unspecified formulation</td></tr><tr><td>39</td><td>Japanese encephalitis SC</td></tr><tr><td>63</td><td>Junin virus</td></tr><tr><td>64</td><td>leishmaniasis</td></tr><tr><td>65</td><td>leprosy</td></tr><tr><td>66</td><td>Lyme disease</td></tr><tr><td>94</td><td>MMRV</td></tr><tr><td>67</td><td>malaria</td></tr><tr><td>68</td><td>melanoma</td></tr><tr><td>32</td><td>meningococcal MPSV4</td></tr><tr><td>103</td><td>meningococcal C conjugate</td></tr><tr><td>114</td><td>meningococcal MCV4P</td></tr><tr><td>108</td><td>meningococcal ACWY, unspecified formulation</td></tr><tr><td>69</td><td>parainfluenza-3</td></tr><tr><td>11</td><td>pertussis</td></tr><tr><td>23</td><td>plague</td></tr><tr><td>33</td><td>pneumococcal polysaccharide PPV23</td></tr><tr><td>100</td><td>pneumococcal conjugate PCV 7</td></tr><tr><td>109</td><td>pneumococcal, unspecified formulation</td></tr><tr><td>70</td><td>Q fever</td></tr><tr><td>18</td><td>rabies, intramuscular injection</td></tr><tr><td>40</td><td>rabies, intradermal injection</td></tr><tr><td>90</td><td>rabies, unspecified formulation</td></tr><tr><td>72</td><td>rheumatic fever</td></tr><tr><td>73</td><td>Rift Valley fever</td></tr><tr><td>34</td><td>RIG</td></tr><tr><td>119</td><td>rotavirus, monovalent</td></tr><tr><td>122</td><td>rotavirus, unspecified formulation</td></tr><tr><td>116</td><td>rotavirus, pentavalent</td></tr><tr><td>74</td><td>rotavirus, tetravalent</td></tr><tr><td>71</td><td>RSV-IGIV</td></tr><tr><td>93</td><td>RSV-MAb</td></tr><tr><td>38</td><td>rubella/mumps</td></tr><tr><td>76</td><td>Staphylococcus bacterio lysate</td></tr><tr><td>113</td><td>Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed</td></tr><tr><td>115</td><td>Tdap</td></tr><tr><td>35</td><td>tetanus toxoid, adsorbed</td></tr><tr><td>112</td><td>tetanus toxoid, unspecified formulation</td></tr><tr><td>77</td><td>Tick-borne encephalitis vaccine (non-US)</td></tr><tr><td>13</td><td>TIG</td></tr><tr><td>95</td><td>TST-OT tine test</td></tr><tr><td>96</td><td>TST-PPD intradermal</td></tr><tr><td>97</td><td>TST-PPD tine test</td></tr><tr><td>98</td><td>TST, unspecified formulation</td></tr><tr><td>78</td><td>tularemia vaccine</td></tr><tr><td>91</td><td>typhoid, unspecified formulation</td></tr><tr><td>25</td><td>typhoid, oral</td></tr><tr><td>41</td><td>typhoid, parenteral</td></tr><tr><td>53</td><td>typhoid, parenteral, AKD (U.S. military)</td></tr><tr><td>101</td><td>typhoid, ViCPs</td></tr><tr><td>75</td><td>Vaccinia (smallpox, mpox), live</td></tr><tr><td>105</td><td>vaccinia (smallpox) diluted</td></tr><tr><td>79</td><td>vaccinia immune globulin</td></tr><tr><td>21</td><td>varicella</td></tr><tr><td>81</td><td>VEE, inactivated</td></tr><tr><td>80</td><td>VEE, live</td></tr><tr><td>92</td><td>VEE, unspecified formulation</td></tr><tr><td>36</td><td>VZIG</td></tr><tr><td>117</td><td>VZIG (IND)</td></tr><tr><td>37</td><td>yellow fever live</td></tr><tr><td>121</td><td>zoster live</td></tr><tr><td>998</td><td>no vaccine administered</td></tr><tr><td>999</td><td>unknown</td></tr><tr><td>99</td><td>RESERVED - do not use</td></tr><tr><td>133</td><td>Pneumococcal conjugate PCV 13</td></tr><tr><td>134</td><td>Japanese Encephalitis IM</td></tr><tr><td>137</td><td>HPV, unspecified formulation</td></tr><tr><td>136</td><td>Meningococcal MCV4O</td></tr><tr><td>135</td><td>Influenza, high-dose, trivalent, PF</td></tr><tr><td>131</td><td>typhus, historical</td></tr><tr><td>132</td><td>DTaP-IPV-HIB-HEP B, historical</td></tr><tr><td>128</td><td>Novel Influenza-H1N1-09, all formulations</td></tr><tr><td>125</td><td>Novel Influenza-H1N1-09, nasal</td></tr><tr><td>126</td><td>Novel influenza-H1N1-09, preservative-free</td></tr><tr><td>127</td><td>Novel influenza-H1N1-09</td></tr><tr><td>138</td><td>Td (adult)</td></tr><tr><td>139</td><td>Td(adult) unspecified formulation</td></tr><tr><td>140</td><td>Influenza, split virus, trivalent, PF</td></tr><tr><td>129</td><td>Japanese Encephalitis, unspecified formulation</td></tr><tr><td>141</td><td>Influenza, split virus, trivalent, preservative</td></tr><tr><td>142</td><td>tetanus toxoid, not adsorbed</td></tr><tr><td>143</td><td>Adenovirus types 4 and 7</td></tr><tr><td>144</td><td>influenza, seasonal, intradermal, preservative free</td></tr><tr><td>145</td><td>RSV-MAb (new)</td></tr><tr><td>146</td><td>DTaP,IPV,Hib,HepB</td></tr><tr><td>147</td><td>meningococcal MCV4, unspecified formulation</td></tr><tr><td>148</td><td>Meningococcal C/Y-HIB PRP</td></tr><tr><td>149</td><td>Influenza, live, quadrivalent, intranasal</td></tr><tr><td>150</td><td>Influenza, split virus, quadrivalent, PF</td></tr><tr><td>151</td><td>influenza nasal, unspecified formulation</td></tr><tr><td>152</td><td>Pneumococcal Conjugate, unspecified formulation</td></tr><tr><td>153</td><td>Influenza, MDCK, trivalent, PF</td></tr><tr><td>154</td><td>Hep A, IG</td></tr><tr><td>155</td><td>Influenza, recombinant, trivalent, PF</td></tr><tr><td>156</td><td>Rho(D)-IG</td></tr><tr><td>157</td><td>Rho(D) -IG IM</td></tr><tr><td>158</td><td>Influenza, split virus, quadrivalent, preservative</td></tr><tr><td>159</td><td>Rho(D) - Unspecified formulation</td></tr><tr><td>160</td><td>Influenza A monovalent (H5N1), ADJUVANTED-2013</td></tr><tr><td>801</td><td>AS03 Adjuvant</td></tr><tr><td>161</td><td>Influenza, injectable,quadrivalent, preservative free, pediatric</td></tr><tr><td>162</td><td>meningococcal B, recombinant</td></tr><tr><td>163</td><td>meningococcal B, OMV</td></tr><tr><td>164</td><td>meningococcal B, unspecified</td></tr><tr><td>165</td><td>HPV9</td></tr><tr><td>166</td><td>influenza, intradermal, quadrivalent, preservative free</td></tr><tr><td>167</td><td>meningococcal, unknown serogroups</td></tr><tr><td>168</td><td>Influenza, adjuvanted, trivalent, PF</td></tr><tr><td>169</td><td>Hep A, live attenuated</td></tr><tr><td>170</td><td>DTAP/IPV/HIB - non-US</td></tr><tr><td>171</td><td>Influenza, MDCK, quadrivalent, PF</td></tr><tr><td>172</td><td>cholera, WC-rBS</td></tr><tr><td>173</td><td>cholera, BivWC</td></tr><tr><td>174</td><td>cholera, live attenuated</td></tr><tr><td>175</td><td>Rabies - IM Diploid cell culture</td></tr><tr><td>176</td><td>Rabies - IM fibroblast culture</td></tr><tr><td>177</td><td>PCV10</td></tr><tr><td>178</td><td>OPV bivalent</td></tr><tr><td>179</td><td>OPV ,monovalent, unspecified</td></tr><tr><td>180</td><td>tetanus immune globulin</td></tr><tr><td>181</td><td>anthrax immune globulin</td></tr><tr><td>182</td><td>OPV, Unspecified</td></tr><tr><td>183</td><td>Yellow fever vaccine live - alt</td></tr><tr><td>184</td><td>Yellow fever, unspecified</td></tr><tr><td>185</td><td>Influenza, recombinant, quadrivalent, PF</td></tr><tr><td>186</td><td>Influenza, MDCK, quadrivalent, preservative</td></tr><tr><td>187</td><td>zoster recombinant</td></tr><tr><td>188</td><td>zoster, unspecified formulation</td></tr><tr><td>189</td><td>HepB-CpG</td></tr><tr><td>190</td><td>Typhoid conjugate vaccine (TCV)</td></tr><tr><td>191</td><td>meningococcal A polysaccharide (non-US)</td></tr><tr><td>192</td><td>meningococcal AC polysaccharide (non-US)</td></tr><tr><td>193</td><td>Hep A-Hep B, pediatric/adolescent</td></tr><tr><td>194</td><td>Influenza, Southern Hemisphere</td></tr><tr><td>195</td><td>DT, IPV adsorbed</td></tr><tr><td>196</td><td>Td, adsorbed, preservative free, adult use, Lf unspecified</td></tr><tr><td>197</td><td>Influenza, high-dose, quadrivalent, PF</td></tr><tr><td>200</td><td>influenza, Southern Hemisphere, pediatric, preservative free</td></tr><tr><td>201</td><td>Influenza, Southern Hemisphere, quadrivalent, PF</td></tr><tr><td>202</td><td>influenza, Southern Hemisphere, quadrivalent, with preservative</td></tr><tr><td>198</td><td>DTP-hepB-Hib Pentavalent Non-US</td></tr><tr><td>203</td><td>meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)</td></tr><tr><td>205</td><td>Influenza, adjuvanted, quadrivalent, PF</td></tr><tr><td>206</td><td>Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection</td></tr><tr><td>207</td><td>COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose</td></tr><tr><td>208</td><td>COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose</td></tr><tr><td>213</td><td>SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED</td></tr><tr><td>210</td><td>COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL</td></tr><tr><td>212</td><td>COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL</td></tr><tr><td>204</td><td>Ebola Zaire vaccine, live, recombinant, 1mL dose</td></tr><tr><td>214</td><td>Ebola, unspecified</td></tr><tr><td>211</td><td>COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL</td></tr><tr><td>500</td><td>COVID-19 Non-US Vaccine, Product Unknown</td></tr><tr><td>501</td><td>COVID-19 IV Non-US Vaccine (QAZCOVID-IN)</td></tr><tr><td>502</td><td>COVID-19 IV Non-US Vaccine (COVAXIN)</td></tr><tr><td>503</td><td>COVID-19 LAV Non-US Vaccine (COVIVAC)</td></tr><tr><td>504</td><td>COVID-19 VVnr Non-US Vaccine (Sputnik Light)</td></tr><tr><td>505</td><td>COVID-19 VVnr Non-US Vaccine (Sputnik V)</td></tr><tr><td>506</td><td>COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology</td></tr><tr><td>507</td><td>COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)</td></tr><tr><td>508</td><td>COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)</td></tr><tr><td>509</td><td>COVID-19 PS Non-US Vaccine (EpiVacCorona)</td></tr><tr><td>510</td><td>COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)</td></tr><tr><td>511</td><td>COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)</td></tr><tr><td>215</td><td>Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF</td></tr><tr><td>216</td><td>Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF</td></tr><tr><td>219</td><td>COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose</td></tr><tr><td>217</td><td>COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose</td></tr><tr><td>218</td><td>COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose</td></tr><tr><td>220</td><td>HepB recombinant, 3-antigen, Al(OH)3</td></tr><tr><td>221</td><td>COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose</td></tr><tr><td>222</td><td>Tick-borne encephalitis, unspecified</td></tr><tr><td>223</td><td>Tick-borne encephalitis, inactivated, PF, 0.25mL</td></tr><tr><td>224</td><td>Tick-borne encephalitis, inactivated, PF, 0.5mL</td></tr><tr><td>225</td><td>COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL</td></tr><tr><td>226</td><td>COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL</td></tr><tr><td>512</td><td>SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)</td></tr><tr><td>513</td><td>SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)</td></tr><tr><td>514</td><td>SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)</td></tr><tr><td>515</td><td>SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)</td></tr><tr><td>516</td><td>COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)</td></tr><tr><td>517</td><td>SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)</td></tr><tr><td>227</td><td>COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose</td></tr><tr><td>228</td><td>COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose</td></tr><tr><td>229</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose</td></tr><tr><td>301</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose</td></tr><tr><td>300</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose</td></tr><tr><td>230</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL</td></tr><tr><td>518</td><td>COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)</td></tr><tr><td>519</td><td>COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna</td></tr><tr><td>520</td><td>COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech</td></tr><tr><td>521</td><td>COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK</td></tr><tr><td>231</td><td>influenza, Southern Hemisphere, high-dose, quadrivalent</td></tr><tr><td>303</td><td>RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF</td></tr><tr><td>304</td><td>Respiratory syncytial virus (RSV), unspecified</td></tr><tr><td>305</td><td>RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF</td></tr><tr><td>306</td><td>RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months</td></tr><tr><td>307</td><td>RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months</td></tr><tr><td>313</td><td>COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL</td></tr><tr><td>308</td><td>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL</td></tr><tr><td>309</td><td>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL</td></tr><tr><td>310</td><td>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL</td></tr><tr><td>312</td><td>COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL</td></tr><tr><td>311</td><td>COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL</td></tr><tr><td>315</td><td>Respiratory syncytial virus (RSV) MAB, unspecified</td></tr><tr><td>314</td><td>Respiratory syncytial virus (RSV) vaccine, unspecified</td></tr><tr><td>316</td><td>Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</td></tr><tr><td>317</td><td>Chikungunya live attenuated vaccine, 0.5 mL, PF</td></tr><tr><td>318</td><td>Anthrax, post-exposure prophylaxis</td></tr><tr><td>319</td><td>Anthrax vaccine, unspecified</td></tr><tr><td>320</td><td>Influenza, MDCK, trivalent, preservative</td></tr><tr><td>321</td><td>Influenza-avian, H5N8, monovalent, PF</td></tr><tr><td>322</td><td>Influenza-avian, H5N8, monovalent, preservative</td></tr><tr><td>324</td><td>Poliovirus, inactivated, fractional-dose (fIPV)</td></tr><tr><td>323</td><td>Influenza-avian, H5, unspecified formulation</td></tr><tr><td>326</td><td>RSV, mRNA, injectable, PF</td></tr><tr><td>327</td><td>Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF</td></tr><tr><td>328</td><td>Meningococcal oligosaccharide (MenACWY), (MenB), PF</td></tr><tr><td>329</td><td>Chikungunya, VLP, recombinant, 0.8 mL, PF</td></tr><tr><td>330</td><td>Dengue fever, unspecified</td></tr><tr><td>331</td><td>Influenza, Southern Hemisphere, trivalent, PF</td></tr><tr><td>325</td><td>Vaccinia (smallpox, mpox), unspecified</td></tr><tr><td>332</td><td>RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF</td></tr><tr><td>333</td><td>Influenza, live, trivalent, intranasal, self/caregiver admin, PF</td></tr><tr><td>302</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose</td></tr></table></li></ul></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "pher"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 4,
"_valueInteger" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/uv/shc-vaccination/ImplementationGuide/hl7.fhir.uv.shc-vaccination"
}
]
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode" : "trial-use",
"_valueCode" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/uv/shc-vaccination/ImplementationGuide/hl7.fhir.uv.shc-vaccination"
}
]
}
}
],
"url" : "http://hl7.org/fhir/uv/shc-vaccination/ValueSet/immunization-all-cvx",
"version" : "1.0.0",
"name" : "ImmunizationAllCvxValueSet",
"title" : "Immunization / All / CVX",
"status" : "active",
"experimental" : false,
"date" : "2025-09-03T20:15:06+00:00",
"publisher" : "HL7 International / Public Health",
"contact" : [
{
"name" : "HL7 International / Public Health",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/pher"
},
{
"system" : "email",
"value" : "vci-ig@mitre.org"
}
]
}
],
"description" : "Contains all CVX codes from <https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx> as of 2025-09-03. This list of codes will not update automatically, so please refer to this URL for\nthe most up-to-date codes.the most up-to-date codes.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001"
}
]
}
],
"compose" : {
"include" : [
{
"system" : "http://hl7.org/fhir/sid/cvx",
"concept" : [
{
"code" : "54",
"display" : "adenovirus, type 4"
},
{
"code" : "55",
"display" : "adenovirus, type 7"
},
{
"code" : "82",
"display" : "adenovirus, unspecified formulation"
},
{
"code" : "24",
"display" : "Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis"
},
{
"code" : "19",
"display" : "BCG"
},
{
"code" : "27",
"display" : "botulinum antitoxin"
},
{
"code" : "26",
"display" : "cholera, unspecified formulation"
},
{
"code" : "29",
"display" : "CMVIG"
},
{
"code" : "56",
"display" : "dengue fever tetravalent"
},
{
"code" : "12",
"display" : "diphtheria antitoxin"
},
{
"code" : "28",
"display" : "DT (pediatric)"
},
{
"code" : "20",
"display" : "DTaP"
},
{
"code" : "106",
"display" : "DTaP, 5 pertussis antigens"
},
{
"code" : "107",
"display" : "DTaP, unspecified formulation"
},
{
"code" : "110",
"display" : "DTaP-Hep B-IPV"
},
{
"code" : "50",
"display" : "DTaP-Hib"
},
{
"code" : "120",
"display" : "DTaP-Hib-IPV"
},
{
"code" : "130",
"display" : "DTaP-IPV"
},
{
"code" : "22",
"display" : "DTP-Hib"
},
{
"code" : "102",
"display" : "DTP-Hib-Hep B"
},
{
"code" : "57",
"display" : "hantavirus"
},
{
"code" : "52",
"display" : "Hep A, adult"
},
{
"code" : "83",
"display" : "Hep A, ped/adol, 2 dose"
},
{
"code" : "84",
"display" : "Hep A, ped/adol, 3 dose"
},
{
"code" : "31",
"display" : "Hep A, pediatric, unspecified formulation"
},
{
"code" : "85",
"display" : "Hep A, unspecified formulation"
},
{
"code" : "104",
"display" : "Hep A-Hep B"
},
{
"code" : "30",
"display" : "HBIG"
},
{
"code" : "42",
"display" : "Hep B, adolescent/high risk infant"
},
{
"code" : "43",
"display" : "Hep B, adult"
},
{
"code" : "44",
"display" : "Hep B, high-dosage, dialysis or IC"
},
{
"code" : "45",
"display" : "Hep B, unspecified formulation"
},
{
"code" : "58",
"display" : "Hep C"
},
{
"code" : "59",
"display" : "Hep E"
},
{
"code" : "60",
"display" : "herpes simplex 2"
},
{
"code" : "46",
"display" : "Hib (PRP-D)"
},
{
"code" : "47",
"display" : "Hib (HbOC)"
},
{
"code" : "48",
"display" : "Hib (PRP-T)"
},
{
"code" : "49",
"display" : "Hib (PRP-OMP)"
},
{
"code" : "17",
"display" : "Hib, unspecified formulation"
},
{
"code" : "51",
"display" : "Hib-Hep B"
},
{
"code" : "61",
"display" : "HIV"
},
{
"code" : "118",
"display" : "HPV, bivalent"
},
{
"code" : "62",
"display" : "HPV, quadrivalent"
},
{
"code" : "86",
"display" : "IG"
},
{
"code" : "87",
"display" : "IGIV"
},
{
"code" : "14",
"display" : "IG, unspecified formulation"
},
{
"code" : "111",
"display" : "Influenza, live, trivalent, intranasal, PF"
},
{
"code" : "15",
"display" : "influenza, split (incl. purified surface antigen)"
},
{
"code" : "16",
"display" : "influenza, whole"
},
{
"code" : "88",
"display" : "influenza, unspecified formulation"
},
{
"code" : "123",
"display" : "influenza, H5N1-1203"
},
{
"code" : "10",
"display" : "IPV"
},
{
"code" : "89",
"display" : "polio, unspecified formulation"
},
{
"code" : "39",
"display" : "Japanese encephalitis SC"
},
{
"code" : "63",
"display" : "Junin virus"
},
{
"code" : "64",
"display" : "leishmaniasis"
},
{
"code" : "65",
"display" : "leprosy"
},
{
"code" : "66",
"display" : "Lyme disease"
},
{
"code" : "94",
"display" : "MMRV"
},
{
"code" : "67",
"display" : "malaria"
},
{
"code" : "68",
"display" : "melanoma"
},
{
"code" : "32",
"display" : "meningococcal MPSV4"
},
{
"code" : "103",
"display" : "meningococcal C conjugate"
},
{
"code" : "114",
"display" : "meningococcal MCV4P"
},
{
"code" : "108",
"display" : "meningococcal ACWY, unspecified formulation"
},
{
"code" : "69",
"display" : "parainfluenza-3"
},
{
"code" : "11",
"display" : "pertussis"
},
{
"code" : "23",
"display" : "plague"
},
{
"code" : "33",
"display" : "pneumococcal polysaccharide PPV23"
},
{
"code" : "100",
"display" : "pneumococcal conjugate PCV 7"
},
{
"code" : "109",
"display" : "pneumococcal, unspecified formulation"
},
{
"code" : "70",
"display" : "Q fever"
},
{
"code" : "18",
"display" : "rabies, intramuscular injection"
},
{
"code" : "40",
"display" : "rabies, intradermal injection"
},
{
"code" : "90",
"display" : "rabies, unspecified formulation"
},
{
"code" : "72",
"display" : "rheumatic fever"
},
{
"code" : "73",
"display" : "Rift Valley fever"
},
{
"code" : "34",
"display" : "RIG"
},
{
"code" : "119",
"display" : "rotavirus, monovalent"
},
{
"code" : "122",
"display" : "rotavirus, unspecified formulation"
},
{
"code" : "116",
"display" : "rotavirus, pentavalent"
},
{
"code" : "74",
"display" : "rotavirus, tetravalent"
},
{
"code" : "71",
"display" : "RSV-IGIV"
},
{
"code" : "93",
"display" : "RSV-MAb"
},
{
"code" : "38",
"display" : "rubella/mumps"
},
{
"code" : "76",
"display" : "Staphylococcus bacterio lysate"
},
{
"code" : "113",
"display" : "Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed"
},
{
"code" : "115",
"display" : "Tdap"
},
{
"code" : "35",
"display" : "tetanus toxoid, adsorbed"
},
{
"code" : "112",
"display" : "tetanus toxoid, unspecified formulation"
},
{
"code" : "77",
"display" : "Tick-borne encephalitis vaccine (non-US)"
},
{
"code" : "13",
"display" : "TIG"
},
{
"code" : "95",
"display" : "TST-OT tine test"
},
{
"code" : "96",
"display" : "TST-PPD intradermal"
},
{
"code" : "97",
"display" : "TST-PPD tine test"
},
{
"code" : "98",
"display" : "TST, unspecified formulation"
},
{
"code" : "78",
"display" : "tularemia vaccine"
},
{
"code" : "91",
"display" : "typhoid, unspecified formulation"
},
{
"code" : "25",
"display" : "typhoid, oral"
},
{
"code" : "41",
"display" : "typhoid, parenteral"
},
{
"code" : "53",
"display" : "typhoid, parenteral, AKD (U.S. military)"
},
{
"code" : "101",
"display" : "typhoid, ViCPs"
},
{
"code" : "75",
"display" : "Vaccinia (smallpox, mpox), live"
},
{
"code" : "105",
"display" : "vaccinia (smallpox) diluted"
},
{
"code" : "79",
"display" : "vaccinia immune globulin"
},
{
"code" : "21",
"display" : "varicella"
},
{
"code" : "81",
"display" : "VEE, inactivated"
},
{
"code" : "80",
"display" : "VEE, live"
},
{
"code" : "92",
"display" : "VEE, unspecified formulation"
},
{
"code" : "36",
"display" : "VZIG"
},
{
"code" : "117",
"display" : "VZIG (IND)"
},
{
"code" : "37",
"display" : "yellow fever live"
},
{
"code" : "121",
"display" : "zoster live"
},
{
"code" : "998",
"display" : "no vaccine administered"
},
{
"code" : "999",
"display" : "unknown"
},
{
"code" : "99",
"display" : "RESERVED - do not use"
},
{
"code" : "133",
"display" : "Pneumococcal conjugate PCV 13"
},
{
"code" : "134",
"display" : "Japanese Encephalitis IM"
},
{
"code" : "137",
"display" : "HPV, unspecified formulation"
},
{
"code" : "136",
"display" : "Meningococcal MCV4O"
},
{
"code" : "135",
"display" : "Influenza, high-dose, trivalent, PF"
},
{
"code" : "131",
"display" : "typhus, historical"
},
{
"code" : "132",
"display" : "DTaP-IPV-HIB-HEP B, historical"
},
{
"code" : "128",
"display" : "Novel Influenza-H1N1-09, all formulations"
},
{
"code" : "125",
"display" : "Novel Influenza-H1N1-09, nasal"
},
{
"code" : "126",
"display" : "Novel influenza-H1N1-09, preservative-free"
},
{
"code" : "127",
"display" : "Novel influenza-H1N1-09"
},
{
"code" : "138",
"display" : "Td (adult)"
},
{
"code" : "139",
"display" : "Td(adult) unspecified formulation"
},
{
"code" : "140",
"display" : "Influenza, split virus, trivalent, PF"
},
{
"code" : "129",
"display" : "Japanese Encephalitis, unspecified formulation"
},
{
"code" : "141",
"display" : "Influenza, split virus, trivalent, preservative"
},
{
"code" : "142",
"display" : "tetanus toxoid, not adsorbed"
},
{
"code" : "143",
"display" : "Adenovirus types 4 and 7"
},
{
"code" : "144",
"display" : "influenza, seasonal, intradermal, preservative free"
},
{
"code" : "145",
"display" : "RSV-MAb (new)"
},
{
"code" : "146",
"display" : "DTaP,IPV,Hib,HepB"
},
{
"code" : "147",
"display" : "meningococcal MCV4, unspecified formulation"
},
{
"code" : "148",
"display" : "Meningococcal C/Y-HIB PRP"
},
{
"code" : "149",
"display" : "Influenza, live, quadrivalent, intranasal"
},
{
"code" : "150",
"display" : "Influenza, split virus, quadrivalent, PF"
},
{
"code" : "151",
"display" : "influenza nasal, unspecified formulation"
},
{
"code" : "152",
"display" : "Pneumococcal Conjugate, unspecified formulation"
},
{
"code" : "153",
"display" : "Influenza, MDCK, trivalent, PF"
},
{
"code" : "154",
"display" : "Hep A, IG"
},
{
"code" : "155",
"display" : "Influenza, recombinant, trivalent, PF"
},
{
"code" : "156",
"display" : "Rho(D)-IG"
},
{
"code" : "157",
"display" : "Rho(D) -IG IM"
},
{
"code" : "158",
"display" : "Influenza, split virus, quadrivalent, preservative"
},
{
"code" : "159",
"display" : "Rho(D) - Unspecified formulation"
},
{
"code" : "160",
"display" : "Influenza A monovalent (H5N1), ADJUVANTED-2013"
},
{
"code" : "801",
"display" : "AS03 Adjuvant"
},
{
"code" : "161",
"display" : "Influenza, injectable,quadrivalent, preservative free, pediatric"
},
{
"code" : "162",
"display" : "meningococcal B, recombinant"
},
{
"code" : "163",
"display" : "meningococcal B, OMV"
},
{
"code" : "164",
"display" : "meningococcal B, unspecified"
},
{
"code" : "165",
"display" : "HPV9"
},
{
"code" : "166",
"display" : "influenza, intradermal, quadrivalent, preservative free"
},
{
"code" : "167",
"display" : "meningococcal, unknown serogroups"
},
{
"code" : "168",
"display" : "Influenza, adjuvanted, trivalent, PF"
},
{
"code" : "169",
"display" : "Hep A, live attenuated"
},
{
"code" : "170",
"display" : "DTAP/IPV/HIB - non-US"
},
{
"code" : "171",
"display" : "Influenza, MDCK, quadrivalent, PF"
},
{
"code" : "172",
"display" : "cholera, WC-rBS"
},
{
"code" : "173",
"display" : "cholera, BivWC"
},
{
"code" : "174",
"display" : "cholera, live attenuated"
},
{
"code" : "175",
"display" : "Rabies - IM Diploid cell culture"
},
{
"code" : "176",
"display" : "Rabies - IM fibroblast culture"
},
{
"code" : "177",
"display" : "PCV10"
},
{
"code" : "178",
"display" : "OPV bivalent"
},
{
"code" : "179",
"display" : "OPV ,monovalent, unspecified"
},
{
"code" : "180",
"display" : "tetanus immune globulin"
},
{
"code" : "181",
"display" : "anthrax immune globulin"
},
{
"code" : "182",
"display" : "OPV, Unspecified"
},
{
"code" : "183",
"display" : "Yellow fever vaccine live - alt"
},
{
"code" : "184",
"display" : "Yellow fever, unspecified"
},
{
"code" : "185",
"display" : "Influenza, recombinant, quadrivalent, PF"
},
{
"code" : "186",
"display" : "Influenza, MDCK, quadrivalent, preservative"
},
{
"code" : "187",
"display" : "zoster recombinant"
},
{
"code" : "188",
"display" : "zoster, unspecified formulation"
},
{
"code" : "189",
"display" : "HepB-CpG"
},
{
"code" : "190",
"display" : "Typhoid conjugate vaccine (TCV)"
},
{
"code" : "191",
"display" : "meningococcal A polysaccharide (non-US)"
},
{
"code" : "192",
"display" : "meningococcal AC polysaccharide (non-US)"
},
{
"code" : "193",
"display" : "Hep A-Hep B, pediatric/adolescent"
},
{
"code" : "194",
"display" : "Influenza, Southern Hemisphere"
},
{
"code" : "195",
"display" : "DT, IPV adsorbed"
},
{
"code" : "196",
"display" : "Td, adsorbed, preservative free, adult use, Lf unspecified"
},
{
"code" : "197",
"display" : "Influenza, high-dose, quadrivalent, PF"
},
{
"code" : "200",
"display" : "influenza, Southern Hemisphere, pediatric, preservative free"
},
{
"code" : "201",
"display" : "Influenza, Southern Hemisphere, quadrivalent, PF"
},
{
"code" : "202",
"display" : "influenza, Southern Hemisphere, quadrivalent, with preservative"
},
{
"code" : "198",
"display" : "DTP-hepB-Hib Pentavalent Non-US"
},
{
"code" : "203",
"display" : "meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)"
},
{
"code" : "205",
"display" : "Influenza, adjuvanted, quadrivalent, PF"
},
{
"code" : "206",
"display" : "Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection"
},
{
"code" : "207",
"display" : "COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"
},
{
"code" : "208",
"display" : "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose"
},
{
"code" : "213",
"display" : "SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED"
},
{
"code" : "210",
"display" : "COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL"
},
{
"code" : "212",
"display" : "COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL"
},
{
"code" : "204",
"display" : "Ebola Zaire vaccine, live, recombinant, 1mL dose"
},
{
"code" : "214",
"display" : "Ebola, unspecified"
},
{
"code" : "211",
"display" : "COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL"
},
{
"code" : "500",
"display" : "COVID-19 Non-US Vaccine, Product Unknown"
},
{
"code" : "501",
"display" : "COVID-19 IV Non-US Vaccine (QAZCOVID-IN)"
},
{
"code" : "502",
"display" : "COVID-19 IV Non-US Vaccine (COVAXIN)"
},
{
"code" : "503",
"display" : "COVID-19 LAV Non-US Vaccine (COVIVAC)"
},
{
"code" : "504",
"display" : "COVID-19 VVnr Non-US Vaccine (Sputnik Light)"
},
{
"code" : "505",
"display" : "COVID-19 VVnr Non-US Vaccine (Sputnik V)"
},
{
"code" : "506",
"display" : "COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology"
},
{
"code" : "507",
"display" : "COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)"
},
{
"code" : "508",
"display" : "COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)"
},
{
"code" : "509",
"display" : "COVID-19 PS Non-US Vaccine (EpiVacCorona)"
},
{
"code" : "510",
"display" : "COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)"
},
{
"code" : "511",
"display" : "COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)"
},
{
"code" : "215",
"display" : "Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF"
},
{
"code" : "216",
"display" : "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF"
},
{
"code" : "219",
"display" : "COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose"
},
{
"code" : "217",
"display" : "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose"
},
{
"code" : "218",
"display" : "COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose"
},
{
"code" : "220",
"display" : "HepB recombinant, 3-antigen, Al(OH)3"
},
{
"code" : "221",
"display" : "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose"
},
{
"code" : "222",
"display" : "Tick-borne encephalitis, unspecified"
},
{
"code" : "223",
"display" : "Tick-borne encephalitis, inactivated, PF, 0.25mL"
},
{
"code" : "224",
"display" : "Tick-borne encephalitis, inactivated, PF, 0.5mL"
},
{
"code" : "225",
"display" : "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL"
},
{
"code" : "226",
"display" : "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL"
},
{
"code" : "512",
"display" : "SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)"
},
{
"code" : "513",
"display" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)"
},
{
"code" : "514",
"display" : "SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)"
},
{
"code" : "515",
"display" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)"
},
{
"code" : "516",
"display" : "COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)"
},
{
"code" : "517",
"display" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)"
},
{
"code" : "227",
"display" : "COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose"
},
{
"code" : "228",
"display" : "COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose"
},
{
"code" : "229",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose"
},
{
"code" : "301",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose"
},
{
"code" : "300",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose"
},
{
"code" : "230",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL"
},
{
"code" : "518",
"display" : "COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"
},
{
"code" : "519",
"display" : "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"
},
{
"code" : "520",
"display" : "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech"
},
{
"code" : "521",
"display" : "COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK"
},
{
"code" : "231",
"display" : "influenza, Southern Hemisphere, high-dose, quadrivalent"
},
{
"code" : "303",
"display" : "RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF"
},
{
"code" : "304",
"display" : "Respiratory syncytial virus (RSV), unspecified"
},
{
"code" : "305",
"display" : "RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF"
},
{
"code" : "306",
"display" : "RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months"
},
{
"code" : "307",
"display" : "RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months"
},
{
"code" : "313",
"display" : "COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL"
},
{
"code" : "308",
"display" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL"
},
{
"code" : "309",
"display" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL"
},
{
"code" : "310",
"display" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL"
},
{
"code" : "312",
"display" : "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL"
},
{
"code" : "311",
"display" : "COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL"
},
{
"code" : "315",
"display" : "Respiratory syncytial virus (RSV) MAB, unspecified"
},
{
"code" : "314",
"display" : "Respiratory syncytial virus (RSV) vaccine, unspecified"
},
{
"code" : "316",
"display" : "Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF"
},
{
"code" : "317",
"display" : "Chikungunya live attenuated vaccine, 0.5 mL, PF"
},
{
"code" : "318",
"display" : "Anthrax, post-exposure prophylaxis"
},
{
"code" : "319",
"display" : "Anthrax vaccine, unspecified"
},
{
"code" : "320",
"display" : "Influenza, MDCK, trivalent, preservative"
},
{
"code" : "321",
"display" : "Influenza-avian, H5N8, monovalent, PF"
},
{
"code" : "322",
"display" : "Influenza-avian, H5N8, monovalent, preservative"
},
{
"code" : "324",
"display" : "Poliovirus, inactivated, fractional-dose (fIPV)"
},
{
"code" : "323",
"display" : "Influenza-avian, H5, unspecified formulation"
},
{
"code" : "326",
"display" : "RSV, mRNA, injectable, PF"
},
{
"code" : "327",
"display" : "Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF"
},
{
"code" : "328",
"display" : "Meningococcal oligosaccharide (MenACWY), (MenB), PF"
},
{
"code" : "329",
"display" : "Chikungunya, VLP, recombinant, 0.8 mL, PF"
},
{
"code" : "330",
"display" : "Dengue fever, unspecified"
},
{
"code" : "331",
"display" : "Influenza, Southern Hemisphere, trivalent, PF"
},
{
"code" : "325",
"display" : "Vaccinia (smallpox, mpox), unspecified"
},
{
"code" : "332",
"display" : "RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF"
},
{
"code" : "333",
"display" : "Influenza, live, trivalent, intranasal, self/caregiver admin, PF"
},
{
"code" : "302",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose"
}
]
}
]
}
}
IG © 2021+ HL7 International / Public Health. Package hl7.fhir.uv.shc-vaccination#1.0.0 based on FHIR 4.0.1. Generated 2025-09-03
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change